Advertisement
Screener

RANI THERAPEUTICS HOLDINGS, INC. (RANI) Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price

0.9 / 5 stars · 6/35 Roast Me

RANI THERAPEUTICS HOLDINGS, INC. Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price

RANI THERAPEUTICS HOLDINGS, INC. (RANI) reported Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price of $4.99 per share for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-31.

Discontinued › Notes › Share-Based Payment Arrangement, Disclosure

us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice · last filed 2022-03-31

  • RANI THERAPEUTICS HOLDINGS, INC. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2021 was $4.99.
Period endShare-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 6 monthShare-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 9 monthShare-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 12 month
2021-12-31$4.99
10-K · filed 2022-03-31
2021-09-30$4.99
10-Q · filed 2021-11-16
2021-06-30$4.99
10-Q · filed 2021-09-13